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Asthma is considered one of the most common 
causes of childhood emergency department visits, 
hospitalizations and missed school days1. There is 
growing evidence suggesting a link between 
vitamin D deficiency and asthma in children. 
Vitamin D was found to play an important role in 
pulmonary health by inhibiting inflammation, 
maintaining regulatory T cells and direct induction 
of innate antimicrobial mechanisms. Also, vitamin 
D was found to have multiple cytokine modulating 
effects through several different cells of the 
immune system. In addition, vitamin D shifts the 
balance of T lymphocyte response from Th1 
phenotype to Th2 phenotype2. The role of vitamin 





levels of 25-hydroxy (25-OH) vitamin D are 
considered the best circulating biomarker of 
vitamin D metabolic status and reflect contributions 
from all sources of vitamin D (i.e., diet and sun 
exposure)4. 
Studies on vitamin D and asthma in children 
have variable results5-8. We sought to investigate 
the relationship between vitamin D status and 
severity and control of bronchial asthma in a group 
of Egyptian asthmatic children and determine the 
critical level of vitamin D that is associated with 
poor asthma status. This is aimed to guide further 
studies using vitamin D supplementation as an 




Objectives: Studies have suggested a significant link between vitamin 
D status and asthma. We sought to determine the cutoff level of25 
hydroxy (25-OH) vitamin D that is significantly linked to asthma 
status in children. Methods: Our cross-sectional study comprised 90 
asthmatic children, aged 2-18 years. They were evaluated clinically 
and classified according to asthma severity and control. Asthma 
control test (ACT) was performed in those aged above 4 years. 
Pulmonary functions were performed in cooperative children (n=59). 
Serum 25-OH vitamin D levels were measured by ELISA in all 
patients. Results: The study comprised 52 boys (57.7%) and 38 girls 
(42.3%) with mean age 7.03±4.36 years. Thirty-six patients (40%) 
had mild asthma, 37 (41%) moderate asthma and 17 (19%) had 
severe asthma. Forty-two patients (46.6%) had controlled asthma; 14 
(15.6%) partially controlled and 34 (37.8%) had uncontrolled asthma. 
ACT score ranged: 11-26, with mean score: 18.9 ± 4.3 SD. Serum 25-
OHvitamin D levels ranged between 2-48 ng/ml (mean± SD: 12.2 ± 9 
ng/ml); levels were comparable among different grades of asthma 
severity (f= 1.975, p=0.145), while the uncontrolled asthma group 
showed the lowest levels (f=8.511, p <0.001). 25-OH vitamin D levels 
correlated positively with ACT score (r= 0.369, p= <0.001) but not 
with inhaled steroids doses or any of the pulmonary function 
parameters. A level of 7.5 ng/ml was associated with partial/complete 
uncontrol of asthma with 81 % sensitivity and 53 % specificity. 
Conclusion: 25-OH vitamin D levels below 7.5 ng/ml are associated 
with poor asthma status in children. 
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PATIENTS AND METHODS 
A cross sectional study was carried out, in the 
period from April 2012 to May 2014. The study 
comprised 90 Egyptian children aged 2-18 years, 
with physician diagnosed, persistent bronchial 
asthma (mild, moderate or severe) on controller 
therapy with or without other forms of allergy.  
They were enrolled consecutively from the 
Pediatric Allergy and Immunology Unit, Children's 
Hospital, Ain Shams University. The following 
patients were excluded from the study: patients with 
intermittent asthma, chronic lung disease other than 
bronchial asthma, patients receiving chronic steroid 
therapy for other reasons than asthma, non-
compliant patients on no/irregular asthma controller 
therapy, subjects having inherited calcium or bone 
disease or having severe liver or kidney disease and 




Detailed medical history was recorded including: 
duration of asthma disease, frequency of asthma 
exacerbations, daytime and night time symptoms, 
vitamin D supplementation, average dose of inhaled 
steroids and/or systemic steroids in the month 
before enrollment and compliance on treatment. 
The dose of inhaled steroids was considered low, 
moderate or high according to Global Initiative for 
Asthma (GINA) 9. Clinical examination was 
performed including detailed chest examination for 
the presence of respiratory distress, wheezes, chest 
infections and/or deformities, in addition to 
complete systematic examination.  
Pulmonary function Tests: 
Pulmonary functions were evaluated for 
cooperative patients aged above 5 years (n=59), 
with special emphasis on peak expiratory flow 
(PEF) using the expiratory flowmeter and forced 
expiratory volume in the first second of forced 
expiration (FEV1) using the dynamic spirometer 
(Master Screen IOS; Jaeger, Höchberg, Germany), 
considering the best of 3 efforts starting with full 
force vital capacity (FVC) maneuvers. FEV % was 
also recorded for each patient (the ratio between 
FEV1 and FVC). The spirometer was calibrated for 
each subject with a 3-L syringe (Cardinal Health, 
Dublin, Ohio). The FVC maneuvers were carried 
out with the child standing and wearing a nose clip. 
Pulmonary function tests were performed and 
interpreted according to the standards of European 




Asthma grading:  
Enrolled patients were classified into mild, 
moderate or severe asthma and into controlled, 
partially controlled or uncontrolled asthma 
according to GINA9. 
Asthma control test (ACT) scoring was carried out 
at the time of enrollment for cooperative subjects 
above the age of 4 years. A score of 19 or less was 
interpreted as uncontrolled asthma11. 
Laboratory investigations included: 
Serum level of 25 25-OH vitamin D was detected in 
all enrolled subjects by ELISA technique using the 
25-OH Vitamin D (total) ELISA kits, DRG 
International, Inc., USA. Results were expressed in 
terms of ng/ml, 25-OH vitamin D levels below 20 
ng/mL were considered deficient12. 
Statistical methods:  
Results were tabulated and analyzed by IBM 
computer using SPSS (statistical program for social 
science version 15). Data were normally 
distributed. Quantitative variables were described 
as mean and standard deviation and qualitative 
variables as number and percentage. Analysis of 
variance [ANOVA] was used to analyze the 
differences between group means (variation among 
and between groups). Correlations among 
numerical variables were tested using the Spearman 
rank correlation. The correlation coefficient 
(Spearman rho) was interpreted according to Hinkle 
et al., 200313. Chi-square (x2) was used to 
determine whether there is a significant difference 
between the expected frequencies and the observed 
frequencies in one or more categories. Receiver-
operating characteristic (ROC) curve analysis was 
used to examine the predictive value of 25-OH 
vitamin D level for asthma uncontrol as defined by 
GINA. A p value ≤ 0.05 was considered significant. 
Ethical considerations: 
The study was conducted in accordance with the 
ethical standards of the Helsinki Declaration of 
1964 as revised in 2008 and the study protocol 
gained approval from the local Ethical Committee 
of the Pediatric department, Faculty of Medicine, 
Ain Shams University. An informed consent was 
obtained from the care givers of enrolled children 
before enrollment in the study, with preservation of 
patients’ anonymity.  
 
RESULTS 
Clinical and epidemiological data of enrolled 
children are demonstrated in table 1. Their mean 
age was 7.03±4.36 years. Four patients had history 
of acute asthma exacerbation in the past 3 months. 
Only three children were on oral vitamin D 
supplementation at time of enrolment. Asthma 
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control test was done in 90 patients and its score 
ranged from 11-26, with mean score: 18.9 ± 4.3 SD. 
All patients were on inhaled corticosteroid therapy 
at time of enrollment. Results of pulmonary 
functions are shown in table 1. A normal pattern 
was found in 23 patients (39%), an obstructive 
pattern in 27 (46%) and a mixed obstructive and 
restrictive pattern in 9 patients (15%).  
Serum 25-OHvitamin D levels ranged between 
2-48 ng/ml (mean± SD: 12.2 ± 9 ng/ml); levels 
were comparable among different grades of asthma 
severity (f= 1.975, p=0.145) (figure 1). According 
to asthma control, the uncontrolled group showed 
the lowest levels of serum 25-OHvitamin D 
(f=8.511, p<0.001) (figure 2). 
Although serum 25-OH vitamin D levels were 
noticed to be the lowest among patients with mixed 
obstructive and restrictive patterns of pulmonary 
functions (mean ± SD: 7.56±6.1 ng/ml) in 
comparison to normal (mean ± SD: 11.2± 6.5 
ng/ml) and obstructive patterns (mean ± SD: 11.7± 
8 ng/ml), yet, the difference between the 3 groups 
did not reach statistical significance (f=1.178, 
p=0.31). 
Similarly, patients who were receiving low dose 
inhaled steroids (n= 29, 32.2%), versus those 
receiving moderate dose (n= 53, 59%) and high 
dose (n= 8, 8.8%), had comparable serum 25-
OHvitamin D levels (mean± SD: 10.48±9.03, 
14.11±13.76, 16.13±10.64, respectively) with no 
significant difference in between (f=1.098, 
p=0.338). 
Serum 25-OH vitamin D levels correlated 
positively with ACT scores (r= 0.369, p= <0.001) 
(figure 3), but not with age (r= -0.189, p= 0.074), 
average daily inhaled steroids (r= 0.204, p= 0.054) 
nor with pulmonary functions parameters, namely 
FEV1 (r= 0.207, p= 0.116), FEV % (r= 0.001, p= 
0.991), FVC (r= 0.21, p= 0.11) and PEF (r= 0.185, 
p= 0.16).  
According to serum 25-OHvitamin D levels, 
patients were classified into 2 groups: vitamin D 
deficient group (25-OHy vitamin D levels < 20 
ng/ml) (n= 72, 80 %) and vitamin D non-deficient 
group (25-OHvitamin D levels ≥ 20 ng/ml) (n= 18, 
20 %). Patients in both groups were comparable 
concerning the distribution of asthma severity (x2= 
0.197, p=0.906) and pulmonary function pattern 
(x2= 0.268, p= 0.874) but they were significantly 
different in terms of asthma control (x2= 12.164, 
p=0.002) with higher percentage of uncontrolled 
cases (n=32; 44.4 %) among the vitamin D deficient 
group versus the non-deficient one (n=2; 11.1%).  
The vitamin D deficient and non-deficient 
groups were further compared in terms of their 
ages, ACT scores, pulmonary function parameters 
and the average daily doses of inhaled steroid and 
the 2 groups were found to be comparable except in 
the ACT test score which was significantly lower 
among the vitamin D deficient group (table 2).  
Serum 25-OH vitamin D levels of the controlled 
asthma group versus the partially controlled and the 
uncontrolled groups were plotted in a ROC curve. 
Levels below 8.5 ng/ml were associated with 
uncontrolled asthma with sensitivity 69 % and 
specificity 66.7 %; positive predictive value 
67.65%; and negative predictive values 68.37% 
(AUC: 0.743; Std error: 0.052; p<0.001, with 95 % 
confidence interval) (figure 4). A lower serum 25 
OH vitamin D cut off level of 7.5 ng/ml could 
predict asthma uncontrol with a better performance: 
sensitivity 81 %, specificity 53%, positive 
predictive value 63.3%; and negative predictive 
value 73.6%.  Patients with 25-OH vitamin D levels 
at or below 7.5 ng/ml had significantly lower FVC 
and ACT in comparison to those having levels 
above 7.5 ng/ml with f= 4.763, p= 0.03 and 
f=11.62, p< 0.001 respectively. Other parameters 
namely FEV1, FEV %, PEF and average daily dose 
of inhaled steroids were all comparable in both 















El-Gamal et al. 
34 
Table 1. Epidemiological and clinical data of enrolled patients 
 
Parameter Classification Number Percentage 
Gender 
 
Boys 52 57.7 % 
Girls 38 42.3 % 
Allergic manifestations 
 
Asthma 90 100% 
Allergic rhinitis 9 10% 
Atopic dermatitis 10 11% 
Urticaria/angioedema 3 3% 
Family history of allergy 
 
Positive 41 46% 
Negative 49 54% 
Asthma severity 
 
Mild 36 40 % 
Moderate 37 41 % 
Severe 17 19 % 
Asthma control 
 
Controlled 42 46.6 % 
Partially controlled 14 15.6 % 
Uncontrolled 34 37.8 % 
Pulmonary function tests 
 
Normal 23 39 % 
Obstructive 27 46 % 
Mixed obstructive and restrictive 9 15 % 
Inhaled steroid dose 
Parameter 
Low 29 32.2 % 
Moderate 53 59 % 
High 8 8.8 % 







Figure 1. Variation of serum 25-OH vitamin D level with asthma severity 
 
 











Figure 3. Correlation between serum 25-OH vitamin D levels and ACT score 
 




Figure 4. ROC curve for serum 25-OH vitamin D levels among controlled versus partially/un-controlled 
asthmatic patients 
 
Table 2. Correlation between DHR & CD11b and CD11b & CD62L in control. 
 




Age (years) 7.2 ± 4.2 5.9 ± 3.7 1.39 0.241 
ACT score 18.47 ± 4.3 20.8 ± 3.8 4.54 0.03 
PEF (L/S) 70.9 ± 15.4 75.3 ± 10.4 0.73 0.398 
FVC (L/S) 90.71±11.81 94.5±9.32 0.907 0.345 
FEV% 92.3 ± 15.6 90.3 ± 10.4 0.178 0.674 
FEV 1 (L/S) 83.7 ± 13.2 85.5 ± 6 0.173 0.679 
Average daily inhaled steroid (ug/day) 224.6±118.9 280 ± 158.2 2.77 0.1 
Frequency of uncontrolled asthma 
n (%) 








This study showed that 80 % of our Egyptian 
asthmatic children had vitamin D deficiency (levels 
below 20 ng/ml). Sunny countries and non-white 
populations are reported to have lower vitamin D 
levels and higher incidence of asthma in 
comparison to the white populations14,15. Darker 
skin pigmentation, seasonal and atmospheric 
factors, with avoidance of sun exposure, all add to 
decreased cutaneous vitamin D synthesis16. Vitamin 
D deficiency in asthmatic children has been 
observed in several controlled studies and vitamin 
D deficient children were found to have 
significantly higher incidence of asthma17-19. A few 
observational studies suggested association between 
low serum 25-OH vitamin D levels and poor 
asthma control and reduced lung function in 
children20-22, whereas some other studies had 
reported adverse impact of vitamin D on asthma5, 23. 
In our study, 25-OH vitamin D levels were 
comparable among different grades of asthma 
severity. However, as regards asthma control, 25-
OH vitamin D was the lowest among patients with 
uncontrolled asthma and the levels correlated 
positively with ACT score. This supports the 
possible role of vitamin D in asthma control in 
children and might reflect the importance of 25-OH 
vitamin D monitoring and hence considering 
supplementation in deficient asthmatics regardless 
the degree of severity. The relationship between 
vitamin D and asthma severity and control is not 
fully understood, with inconsistent outcomes 
among different studies. For instance, some studies 
reported that children with poorly controlled 
refractory asthma had lower 25-OH vitamin D 
levels than those with moderately controlled or 
controlled asthma21, 24. An inverse relation between 
serum 25-OH vitamin D levels and asthma severity 
and exacerbations has been observed in a cross-
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sectional study of 616 Costa Rican children20. Other 
studies failed to find a significant relation between 
vitamin D levels and asthma severity and control in 
children25-29. The different results among studies 
might reflect the differences among populations 
with respect to genetic, racial and environmental 
factor.  
In our study, a cut off level for 25-OH vitamin D 
of 7.5 ng/ml could discriminate between controlled 
and partially/un-controlled patients which is 
different from the well-defined values for 25-OH 
vitamin D levels required for bone health (≥ 20 
ng/ml)12. Different cut-off levels of 25-OH vitamin 
D in different disorders have also been reported. A 
25-OH vitamin D level of 25 ng/ml could 
discriminate between Egyptian asthmatic adults 
(n=70) and healthy controls (n=20) with sensitivity 
of 80% and specificity of 85% 30, while a level of 
17.23 ng/mL was observed in another study as a 
cutoff between a group of 30 Egyptian patients with 
alopecia areata versus 20 healthy controls31. In 
rheumatoid arthritis, 25-OH vitamin D levels of 
12.3 and 17.9 ng/ml could predict high and low 
disease activity respectively in 102 adult patients 
from Saudi Arabia32. 
In our series, 25-OH vitamin D levels were 
comparable among different patterns of pulmonary 
dysfunction although they seemed to be lower 
among patients with mixed obstructive and 
restrictive pattern in comparison to normal and 
obstructive patterns. 25-OH vitamin D levels did 
not correlate with any of the pulmonary functions 
parameters, neither were there differences in 
pulmonary function parameters between vitamin D 
deficient (below 20 ng/ml12) and non-deficient 
groups. However, a 25-OH vitamin D level of 7.5 
ng/ml seemed to be critical in our studied asthmatic 
children as below this level, both asthma control 
and FVC were found to be poor. Devereux et al. 
showed no association between vitamin D levels 
and pulmonary functions in 80 adult asthmatics in 
the UK28. A study evaluating 25-OH  vitamin D 
levels in 1315 children, aged 5–18 years, found that 
those with insufficient vitamin D levels had 
significantly lower FVC and lower FEV1 on 
pulmonary function tests when compared to those 
with sufficient levels33. Also, among 1,024 children 
with persistent asthma treated with inhaled steroids 
a greater improvement of lung function over one 
year was noticed in children with vitamin D 
sufficiency versus deficiency34. Contrary to our 
findings, significant positive correlation between 
serum 25-OH vitamin D levels and pulmonary 
function parameters has been observed by several 
researchers35-38. In a pediatric randomized control 
trial, 500 units of vitamin D supplementation daily 
for 6 months showed decreased asthma 
exacerbation though vitamin D levels did not 
change before and after supplementation, while 
lung functions improved significantly39.  
We did not observe any significant relation 
between 25-OH vitamin D levels and the average 
daily doses of inhaled steroids. The relationship 
between inhaled steroid dose and 25-OH vitamin D 
level in asthmatic subjects is not clear with some 
studies supporting the role of vitamin D in 
decreasing the inhaled steroid requirements7,24 
while others denying this role25,33. 
Our study has some limitations, first, being a 
cross sectional one, besides, lung development and 
function and development of allergies were 
observed to be affected not only by the current 
vitamin D status but also by maternal and in-utero 
vitamin D levels40 which was not investigated in 
our work.  
In conclusion, our study demonstrated a 
significant relation between serum 25-OH vitamin 
D level and degree of asthma control in children 
with a level at or below 7.5 ng/ml being associated 
with poor asthma control and lower pulmonary 
functions. Further longitudinal randomized 
controlled studies are warranted for investigating 
the effect of vitamin D supplementation on asthma 
control. More insight onto the common 
polymorphisms in the vitamin D receptor and other 
genes in the vitamin D pathway and their relation to 
asthma severity and control is worthwhile.  
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